ProfileGDS4718 / 65718_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 47% 44% 65% 42% 51% 43% 47% 45% 51% 47% 49% 49% 47% 50% 43% 50% 51% 51% 43% 58% 49% 50% 48% 54% 49% 51% 53% 50% 49% 45% 43% 54% 46% 45% 50% 56% 45% 50% 47% 67% 47% 46% 66% 52% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.3760547
GSM549102patient 115, normal, homogenized [OPG study]5.2280544
GSM549104patient 119, normal, homogenized [OPG study]6.4985565
GSM549108patient 138, normal, homogenized [OPG study]5.1686542
GSM549119patient 077, normal, homogenized [OPG study]5.5784751
GSM549133patient 032, cancer, homogenized [OPG study]5.0556243
GSM549139patient 042, cancer, homogenized [OPG study]5.3221147
GSM549099patient 107, normal, homogenized [OPG study]5.2602645
GSM549109patient 139, normal, homogenized [OPG study]5.5695551
GSM549110patient 046, normal, homogenized [OPG study]5.3644747
GSM549114patient 063, normal, homogenized [OPG study]5.3878349
GSM549122patient 082, normal, homogenized [OPG study]5.4885349
GSM549134patient 033, cancer, homogenized [OPG study]5.3497647
GSM549136patient 036, cancer, homogenized [OPG study]5.4571450
GSM549140patient 044, cancer, homogenized [OPG study]5.1235443
GSM549111patient 047, normal, homogenized [OPG study]5.4678350
GSM549113patient 057, normal, homogenized [OPG study]5.528151
GSM549132patient 031, cancer, homogenized [OPG study]5.5498251
GSM549137patient 038, cancer, homogenized [OPG study]5.1172243
GSM549142patient 047, cancer, homogenized [OPG study]6.1229358
GSM549100patient 110, normal, homogenized [OPG study]5.4727349
GSM549107patient 135, normal, homogenized [OPG study]5.4845350
GSM549115patient 068, normal, homogenized [OPG study]5.3476748
GSM549116patient 072, normal, homogenized [OPG study]5.7113654
GSM549120patient 078, normal, homogenized [OPG study]5.4598449
GSM549131patient 030, cancer, homogenized [OPG study]5.5151451
GSM549118patient 074, normal, homogenized [OPG study]5.7111953
GSM549129patient 027, cancer, homogenized [OPG study]5.5258750
GSM549123patient 088, normal, homogenized [OPG study]5.4350849
GSM549124patient 006, cancer, homogenized [OPG study]5.2975345
GSM549126patient 015, cancer, homogenized [OPG study]5.1419143
GSM549128patient 025, cancer, homogenized [OPG study]5.7502354
GSM549103patient 117, normal, homogenized [OPG study]5.3403646
GSM549117patient 073, normal, homogenized [OPG study]5.1890545
GSM549138patient 041, cancer, homogenized [OPG study]5.4802550
GSM549141patient 045, cancer, homogenized [OPG study]5.8603756
GSM549130patient 028, cancer, homogenized [OPG study]5.2285245
GSM549101patient 111, normal, homogenized [OPG study]5.5684350
GSM549105patient 128, normal, homogenized [OPG study]5.3806447
GSM549106patient 134, normal, homogenized [OPG study]6.6529767
GSM549112patient 048, normal, homogenized [OPG study]5.3337147
GSM549125patient 011, cancer, homogenized [OPG study]5.3059646
GSM549127patient 024, cancer, homogenized [OPG study]6.6415366
GSM549135patient 035, cancer, homogenized [OPG study]5.626952